108 results found

On May 13, the Second Section of the Superior Court of Justice (STJ) set an important precedent regarding the liability of internet service providers when deciding Special Appeal # 1,512,647.

There are currently thirty-two (32) bills pending before the House of Representatives and nine (9) before the Senate that seek to amend the Brazilian Patent Statute (Law # 9,279, of May 14th, 1996).

Brazil's Patent and Trademark Office has opened a 60-day public consultation period to gather stakeholder input on regulatory frameworks for electronic game registration.

Brazil's new Statute #15,496/2026 establishes PROFERT, a comprehensive program designed to boost domestic fertilizer production and reduce the country's external dependence on agricultural inputs. The legislation introduces mandatory blending requirements for domestically produced fertilizers starting July 2027 and creates financing mechanisms through BNDES to support qualified producers of fertilizers, bioinputs, and biofertilizers.

Brazil's Ministry of Health is advancing the regulatory framework for the National Health Strategy for the Health Economic-Industrial Complex (ENSCEIS), established by Statute #15,471 of July 20, 2026. The framework aims to strengthen domestic production and innovation capacity in the health sector while reducing dependence on foreign technology and expanding access to strategic health technologies for Brazil's public healthcare system.

IP Bridge and Dolby have filed lawsuits against Chinese electronics manufacturer Skyworth and several Brazilian companies in Rio de Janeiro State Court over alleged infringement of AVC standard-essential patents. A court-appointed expert has now issued findings on whether Skyworth's televisions infringe the asserted IP Bridge patent and whether it qualifies as essential to the AVC standard.

The Brazilian Patent and Trademark Office has introduced significant updates to its Trademark Guidelines, effective June 2026, reshaping how high-renown trademarks are recognized and how Madrid Protocol filings are processed. These changes offer new strategic opportunities for multinational brands while requiring procedural adjustments for trademark applicants operating in Brazil.

Brazil's food and drug regulatory agency Anvisa has initiated administrative proceedings to review advertising regulations for medicines and food products, responding to constitutional challenges...

Brazil's health regulatory agency Anvisa has unveiled a comprehensive action plan to address its substantial backlog of drug marketing approval applications...

Brazil's Data Protection Agency has issued new guidelines establishing deadlines and requirements for transparency reports under the Digital Statute for Children and Adolescents. The first reports must be published by September 17, 2026, covering data from platforms with over one million users under 18 years old.

Brazil's Data Protection Agency has opened a public consultation on draft guidelines that will define which digital platforms and service providers fall under the scope of the new Digital ECA...

The Brazilian Patent and Trademark Office has opened a public consultation on new regulations that would introduce fast-track processing options for industrial design applications, a mechanism not currently available in this category. The proposed framework includes priority pathways for elderly applicants, persons with disabilities, startups, litigation-related cases, and applications tied to patent filings or government permits, alongside a pilot project with quota-based allocation.

The Brazilian Patent and Trademark Office has introduced new regulations allowing patent applicants to submit up to three fast-track requests per month for applications classified under IPC H04, marking a shift from the previous single-request limitation. While this change aims to improve access to expedited patent processing, questions remain about whether it adequately addresses the needs of innovation-intensive sectors like telecommunications and information technology that face ongoing challenges

According to article 2, ¶1 of Normative Instruction #74/2017, the applicant will have the entire responsibility for guarding the confidential information and for its transformation in hash summary.

As the Trump administration imposes a new round of tariffs, Brazil's federal government threatens to invoke the Economic Reciprocity Law, potentially targeting intellectual property rights as a strategic countermeasure. This move could significantly impact American pharmaceutical, agrochemical, and technology companies operating in Brazil, raising questions about the balance between trade retaliation and long-term legal security.

Brazil's health regulatory authority Anvisa and Mexico's Cofepris are establishing an expedited regulatory pathway that would allow medicinal products already approved by Anvisa to undergo streamlined...

Since 2003, the telecom industry in Brazil has been following the lawsuit filed by Ericsson challenging the validity of a Brazilian patent owned by a local non-practicing entity, ...

Brazil's Drug Market Regulation Chamber has introduced significant modifications to its drug pricing framework through Rule #7/2026, adjusting criteria for new drugs, biosimilars, and generic medications. The regulatory changes simplify documentation requirements for biosimilars while clarifying provisions for generic drug pricing, though several industry concerns regarding off-label treatment comparisons and retroactive application remain unresolved.